10:02 AM EDT, 03/31/2025 (MT Newswires) -- Monro ( MNRO ) said Monday that Peter Fitzsimmons has been named president and chief executive officer, effective immediately. Fitzsimmons, a partner and managing director of consulting firm AlixPartners, succeeds Michael Broderick, who stepped down after the board determined a leadership change was necessary. Fitzsimmons appointment was made as part of a strategic...

10:06 AM EDT, 03/31/2025 (MT Newswires) -- Gyre Therapeutics ( GYRE ) said Monday that China's National Medical Products Administration approved its application to conduct a clinical trial evaluating pirfenidone capsules for radiation-induced lung injury, with or without immune-related pneumonitis. The company said it expects to start the phase 2/3 trial to assess dosing and efficacy in H2 2025 at...

10:05 AM EDT, 03/31/2025 (MT Newswires) -- Abbott Laboratories ( ABT ) said Monday new results from a trial showed that the TriClip transcatheter edge-to-edge repair system to treat leaky heart valves provided substantial and sustained improvements in the severity of the condition after two years. The data also showed that that the device significantly reduced the rate of heart...

10:03 AM EDT, 03/31/2025 (MT Newswires) -- NeOnc Technologies Holdings ( NTHI ) said Monday that the US Food and Drug Administration has granted rare pediatric disease designation to perillyl alcohol, also known as NEO100, for the treatment of pediatric-type diffuse high-grade gliomas. The company said the FDA designation was based on findings that pediatric-type diffuse high-grade gliomas meets the...